In Government Employees Health Association (GEHA) v. Actelion Pharmaceuticals Ltd., GEHA alleged that Actelion, the manufacturer of Tracleer, engaged in an anticompetitive scheme to delay entry of a generic version of the drug. Eric Gaier provided an expert report and deposition testimony regarding market definition and market power on behalf of Actelion. The matter is ongoing.
Partner with a firm that delivers rigorous economic research and practical advice.
By using this site, you agree to our updated Cookie Policy, Privacy Policy, and our Terms & Conditions.
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use cookies, please see our Cookie Policy and Privacy Policy.
